Skip to main content

Table 4 Treatment outcomes in 149 patients with imported loiasis

From: Imported loiasis in France: a retrospective analysis of 167 cases with comparison between sub-Saharan and non sub-Saharan African patients

 ivermectinabdiethylcarbamazinecdivermectina then diethylcarbamazinec
N = 113 (75.8%)N = 10 (6.7%)N = 26 (17.4%)
N%N%N%
Outcomes:
 failure108.822027.6
 full cure5952.2002076.9
 partial cure0055027.6
 loss of follow up4438.933027.6
 preventive treatment of post-treatment reaction1513.2440726.9
 post-treatment reaction54.4220415.3
  1. abetween 1and 6 courses (1 course: 62.8%; 2: 17.8%; 3: 7.7%; 4: 6.2%; 5: 2.3%; 6: 3.1%), 10 (7.1%) patients received only 1 course, associated with albendazole in 4 cases
  2. b200 μg/kg per course
  3. cprogressive dosage (initial dosage between 10 and 75 mg, final dosage 200–400 mg for 21 days)
  4. dTwo patients with a high microfilaremia (38,200 and 50,000/mL, respectively) were treated with filariopheresis followed by diethylcarbamazine without significant adverse event